Connect Biopharma Holdings Limited (CNTB) vs OKYO Pharma Limited (OKYO)
A side-by-side comparison of Connect Biopharma Holdings Limited and OKYO Pharma Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.97HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
OKYO
OKYO Pharma Limited
$1.49HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — CNTB vs OKYO
growth of $100 · dividends reinvested · last 4yCNTB +11.3% (+2.7%/yr)OKYO -59.4% (-20.2%/yr)CNTB compounded faster over this window
CNTB OKYO
CNTB vs OKYO: by the numbers
- •CNTB is the larger company ($61M vs $57M market cap).
- •Both run net losses; OKYO's is the smaller (0.00% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | OKYO |
|---|---|---|
| P/B ratio | 2.27 | 4.62 |
Profitability
| Metric | CNTB | OKYO |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -90740.62% | 0.00% |
| Net margin | -86687.50% | 0.00% |
| ROE | -132.16% | -72.55% |
| ROIC | -136.77% | -68.91% |
Growth (annualized)
| Metric | CNTB | OKYO |
|---|---|---|
| Total return CAGR (5Y) | -47.22% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.